NKGen Biotech (NKGN) Institutional Ownership $0.13 -0.01 (-8.62%) As of 08/28/2025 12:37 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NKGen Biotech (NYSE:NKGN)CurrentInstitutional OwnershipPercentage76.17%Number ofInstitutional Buyers(last 12 months)6TotalInstitutional Inflows(last 12 months)$478.28KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$934.03K Get NKGN Insider Trade Alerts Want to know when executives and insiders are buying or selling NKGen Biotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data NKGN Institutional Buying and Selling by Quarter NKGen Biotech Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/8/2025 University of Chicago325,000$58K0.1%-40.9%0.723% 2/25/2025 Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/17/2025 Polar Asset Management Partners Inc.500,000$328K0.0%-57.7%1.112% 2/13/2025 Advisory Research Inc.43,088$28K0.0%N/A0.096% 2/12/2025 Geode Capital Management LLC127,168$83K0.0%+12.8%0.283% 2/11/2025 Kepos Capital LP230,022$151K0.2%N/A0.512% 2/11/2025 Magnetar Financial LLC267,508$175K0.0%N/A0.595% 2/7/2025 Sequoia Financial Advisors LLC156,000$102K0.0%+126.1%0.347% 11/15/2024 Polar Asset Management Partners Inc.1,181,872$447K0.0%+9.4%3.342% 10/22/2024 Sequoia Financial Advisors LLC69,000$26K0.0%+273.0%0.268% 5/1/2024 Sequoia Financial Advisors LLC16,000$30K0.0%N/A0.070% 3/14/2024 University of Chicago550,000$1.51M2.1%N/A2.513% (Data available from 1/1/2016 forward) NKGN Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NKGN shares? During the previous two years, the following institutional investors and hedge funds held shares of NKGen Biotech shares: Polar Asset Management Partners Inc. ($328K), Magnetar Financial LLC ($175K), Kepos Capital LP ($151K), Sequoia Financial Advisors LLC ($102K), Geode Capital Management LLC ($83K), and University of Chicago ($58K), and Advisory Research Inc. ($28K).Learn more on NKGen Biotech's institutional investors. What percentage of NKGen Biotech's stock is owned by institutional investors? 76.17% of NKGen Biotech's stock is owned by institutional investors. Learn more on NKGN's institutional investor holdings. Which institutional investors have been buying NKGen Biotech's stock? The following institutional investors have purchased NKGen Biotech's stock in the last 24 months: University of Chicago ($550K), Magnetar Financial LLC ($267.51K), Kepos Capital LP ($230.02K), Sequoia Financial Advisors LLC ($153.50K), Polar Asset Management Partners Inc. ($101.87K), Advisory Research Inc. ($43.09K), and Geode Capital Management LLC ($14.45K). How much institutional buying is happening at NKGen Biotech? Institutional investors have bought a total of 794,444 shares in the last 24 months. This purchase volume represents approximately $478.28K in transactions. Which of NKGen Biotech's major shareholders have been selling company stock? The following institutional investors have sold NKGen Biotech stock in the last 24 months: Polar Asset Management Partners Inc. ($1.36M), and University of Chicago ($225K). How much institutional selling is happening at NKGen Biotech? Institutional investors have sold a total of 1,588,744 shares in the last 24 months. This volume of shares sold represents approximately $934.03K in transactions. Related Companies NanoViricides Major Shareholders Passage Bio Major Shareholders BioAtla Major Shareholders Relmada Therapeutics Major Shareholders Lisata Therapeutics Major Shareholders Cingulate Major Shareholders Elevation Oncology Major Shareholders Soligenix Major Shareholders Promis Neurosciences Major Shareholders Aytu BioPharma Major Shareholders This page (NYSE:NKGN) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access